Navigation Links
New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir

oncomitant oral antidiabetes treatment may require adjustment. Levemir® should not be diluted or mixed with any other insulin preparations or used in insulin infusion pumps. Inadequate dosing or discontinuation of treatment may lead to hyperglycemia and, in patients with type 1 diabetes, diabetic ketoacidosis. Insulin may cause sodium retention and edema, particularly if previously poor metabolic control is improved by intensified insulin therapy. Dose and timing of administration may need to be adjusted to reduce the risk of hypoglycemia in patients being switched to Levemir from other intermediate or long-acting insulin preparations. The dose of Levemir may need to be adjusted in patients with renal or hepatic impairment.

*Whether the observed differences in weight represent true differences in the effects of Levemir® and other therapies is not known, since these trials were not blinded and the protocols (e.g., diet and exercise instructions and monitoring) were not specifically directed at exploring hypotheses related to weight effects. The clinical significance of the observed differences has not been established.

Prescribing information for Levemir® is available by contacting Novo Nordisk or visiting novonordisk-us.com.

Levemir® and FlexPen® are registered trademarks of Novo Nordisk A/S.

# # #


Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 23,600 e
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/1/2015)... 1, 2015  Misonix, Inc. (NASDAQ: MSON ... manufactures and markets innovative therapeutic ultrasonic products for ... surgery, laparoscopic surgery and other surgical applications, announced ... the third quarter fiscal year 2015 on Thursday, ... conference call that same day, Thursday, May 7, ...
(Date:5/1/2015)... 2015  Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: ... following the results of the Phase 3 Rocket 1 ... trial failing to meet its end points, compelling data ... from future studies. An analyst report on ... financial review, analyst summary, valuation, and recommendation can be ...
(Date:4/30/2015)... Calif., April 30, 2015 Omnicell, Inc. (NASDAQ: ... management solutions to healthcare systems, today announced results for ... GAAP results: Revenue for the first quarter of 2015 ... the first quarter of 2014, and down $5.3 million ... First quarter 2015 net income as reported in ...
Breaking Medicine Technology:Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27
... that a new market research report is available in its ... 2017 http://www.reportlinker.com/p0333693/Europe-ENT-Devices-Market-Outlook-to-2017.html ... Summary GlobalData,s new report, "Europe ENT Devices ... Europe ENT Devices market – France, Germany, Italy, Spain and ...
... 20, 2011 Boston Scientific Corporation (NYSE: BSX ... March 31, 2011, as well as net sales and earnings ... guidance for the full year 2011. The Company exceeded its ... EPS guidance for the full year 2011. First quarter GAAP ...
Cached Medicine Technology:Reportlinker Adds Europe ENT Devices Market Outlook to 2017 2Reportlinker Adds Europe ENT Devices Market Outlook to 2017 3Reportlinker Adds Europe ENT Devices Market Outlook to 2017 4Reportlinker Adds Europe ENT Devices Market Outlook to 2017 5Reportlinker Adds Europe ENT Devices Market Outlook to 2017 6Reportlinker Adds Europe ENT Devices Market Outlook to 2017 7Reportlinker Adds Europe ENT Devices Market Outlook to 2017 8Reportlinker Adds Europe ENT Devices Market Outlook to 2017 9Reportlinker Adds Europe ENT Devices Market Outlook to 2017 10Reportlinker Adds Europe ENT Devices Market Outlook to 2017 11Reportlinker Adds Europe ENT Devices Market Outlook to 2017 12Reportlinker Adds Europe ENT Devices Market Outlook to 2017 13Boston Scientific Announces Results for First Quarter Ended March 31, 2011 2Boston Scientific Announces Results for First Quarter Ended March 31, 2011 3Boston Scientific Announces Results for First Quarter Ended March 31, 2011 4Boston Scientific Announces Results for First Quarter Ended March 31, 2011 5Boston Scientific Announces Results for First Quarter Ended March 31, 2011 6Boston Scientific Announces Results for First Quarter Ended March 31, 2011 7Boston Scientific Announces Results for First Quarter Ended March 31, 2011 8Boston Scientific Announces Results for First Quarter Ended March 31, 2011 9Boston Scientific Announces Results for First Quarter Ended March 31, 2011 10Boston Scientific Announces Results for First Quarter Ended March 31, 2011 11Boston Scientific Announces Results for First Quarter Ended March 31, 2011 12Boston Scientific Announces Results for First Quarter Ended March 31, 2011 13Boston Scientific Announces Results for First Quarter Ended March 31, 2011 14Boston Scientific Announces Results for First Quarter Ended March 31, 2011 15Boston Scientific Announces Results for First Quarter Ended March 31, 2011 16Boston Scientific Announces Results for First Quarter Ended March 31, 2011 17Boston Scientific Announces Results for First Quarter Ended March 31, 2011 18
(Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood ... their reclaimed wood products at the 27th annual International ... in NYC this May. Their newest offerings, Vat 35, ... texture and color to North America's platform for global ... and color in the design world and we're excited ...
(Date:5/1/2015)... May 01, 2015 Royal River Natural ... Maine, reports on a new study that found two ... swelling and improved physical function as well as standard ... osteoarthritis of the knee. , The report is part ... for Well Being® ,” which Royal River Natural Foods ...
(Date:5/1/2015)... TROY Healthcare Solutions is proud to ... Group (RUG) Conference in Atlanta, GA from May 6 ... Conference provides a forum for client-to-client presentations, continuing education ... of electronic medical record operations, as well as showcasing ... In addition to sponsoring the event, TROY Healthcare Solutions ...
(Date:5/1/2015)... Hope For The Warriors® thanks All ... The Warriors® and military families. All American Ford presented ... The Warriors®, a national nonprofit dedicated to restoring a ... hope for our service members and our military families. ... collected and matched small autograph fee from fans and ...
(Date:5/1/2015)... Yorba Linda, CA (PRWEB) May 01, 2015 ... of our genetic makeup and the interplay of genes ... Keeping up with developments can be daunting. , LabRoots, ... sciences and clinical diagnostics professionals, will soon host its ... Genomics. , At BioConference Live Genetics and Genomics ...
Breaking Medicine News(10 mins):Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3
... HealthPartners hosts nine physicians from Chongqing Bureau ... HealthPartners,Institute for Medical Education is hosting ... ever to visit Minnesota. During their,three-month stay, ... care, learn about health plan and hospital ...
... 5pm Today, LAWRENCE, Mass., May 12 NxStage ... innovative dialysis products,today announced its financial results for the ... first quarter of 2008 were $31.0 million, compared to,$8.4 ... million in the fourth,quarter of 2007. Revenues in the ...
... heart failure in those with Duchenne muscular dystrophy , , ... muscular dystrophy often suffer from heart failure, but Viagra ... a new Canadian study finds. , In experiments with ... by preventing the breakdown of a compound called cGMP, ...
... impact and other influences are limiting the growth ... of frequency and severity of ... AOC ),the leading provider of global risk management and consulting ... care industry,finding for the first time in nine years of ...
... China, May 12 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Co., Inc., ... modernized traditional Chinese medicine ("TCM") based in,Chengdu, China, ... Roth Third,Annual China Discovery Tour on Tuesday, May ... will be held at the Regent Hotel in ...
... Gentiva Health,Services, Inc. (Nasdaq: GTIV ), the nation,s ... it is scheduled to,present from 2:30 p.m. to 2:55 ... Investment Research Global Health Care Conference in New York., ... via a live audio web,cast, which may be accessed ...
Cached Medicine News:Health News:First Major Chinese Medical Delegation Visits Minnesota 2Health News:NxStage Medical Reports First Quarter 2008 Results 2Health News:NxStage Medical Reports First Quarter 2008 Results 3Health News:NxStage Medical Reports First Quarter 2008 Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 5Health News:NxStage Medical Reports First Quarter 2008 Results 6Health News:NxStage Medical Reports First Quarter 2008 Results 7Health News:NxStage Medical Reports First Quarter 2008 Results 8Health News:NxStage Medical Reports First Quarter 2008 Results 9Health News:NxStage Medical Reports First Quarter 2008 Results 10Health News:NxStage Medical Reports First Quarter 2008 Results 11Health News:Viagra May Protect Hearts of Some Muscular Dystrophy Patients 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 3Health News:Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 3
... The NGAL ELISA Kit is intended ... fluids, (e.g. plasma, serum, urine), tissue extracts ... is dramatically increased, especially in urine, as ... and in ongoing renal repair processes. NGAL ...
... Light Head is commonly found in Heart rooms where ... the third light head being used to illuminate the ... is also a favorite in trauma rooms should there ... the same time. With 137,000 Lux output per ...
... the only medical grade DVD recorder that features ... two exclusive features DVORECOVERY™ and DVOFAST™, making this ... ever designed. DVORECOVERY enables the end user to ... outage. DVOFAST enables you to remove a recorded ...
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
Medicine Products: